nach oben

Strahlentherapie und Onkologie

Erschienen in:

01.10.2013 | Original article

Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer

verfasst von: T. Rutkowski, A. Wygoda, K. Składowski, B. Hejduk, R. Rutkowski, Z. Kołosza, B. Maciejewski

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Background and purpose

Tumor volume (TV) is recognized as a prognostic factor of treatment outcome for head and neck tumors but is not routinely included in the treatment decision-making process. The purpose of the study was to define its prognostic role for patients with T2 laryngeal cancer.

Material and methods

TV of 160 patients who underwent RT between 2002 and 2006 for T2 laryngeal squamous cell carcinoma were reviewed. The tumor was located in the glottis and epiglottis in 82 (51 %) and 78 (49 %) patients, respectively. TV was manually contoured on pretreatment, planning, contrast-enhanced CT scans and the volumetric measurement (cm³) was calculated by the volume algorithm.

Results

The median TV value was 2.01 cm³ (range 0.15–21.68 cm³). The median TV was significantly lower in patients with glottic tumors (p < 0.0001), N0 (p < 0.001), or well histopatologically differentiated tumors (p = 0.01). A significant correlation between TV, hemoglobin concentration (p < 0.01), and total dose (TD; p < 0.001) was observed. On univariate analyses, TV influenced local control (LC; p = 0.02) and overall survival (OS, p < 0.001). On multivariate analysis, both age (HR 1.038, p = 0.03) and TV (HR = 1.075, p = 0.01) remained significantly related to LC and OS (age: HR 1.038, p = 0.005; TV: HR 1.097, p = 0.0001).

Conclusion

Large TV worsen prognosis of patients with T2 laryngeal cancer. A large TV is more common for supraglottic, poorly differentiated tumors and may suggest higher risk of nodal spread. The routine estimation of TV prior to therapy may be essential in order to select the best treatment option for patients with T2 laryngeal cancer.

Baghi M, Mack MG, Hambek M et al (2007) Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy. Head Neck 29:104–108PubMedCrossRef

Bentzen SM, Thames HD (1996) Tumor volume and local control probability: clinical data and radiobiological interpretations. Int J Radiat Oncol Biol Phys 36:247–251PubMedCrossRef

Bosaeus I, Daneryd P, Lundholm K (2002) Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. J Nutr 132:3465S–3466SPubMed

Brenner DJ (1993) Dose, volume, and tumor-control predictions in radiotherapy. Int J Radiat Oncol Biol Phys 26:171–179PubMedCrossRef

Chen SW, Yang SN, Liang JA et al (2009) Prognostic impact of tumor volume in patients with stage III–IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy. Head Neck 31:709–716PubMedCrossRef

Colasanto JM, Prasad P, Nash MA et al (2005) Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park) 19:371–379

Chung EJ, Lee NJ, Baek SK et al (2009) Clinical efficacy of primary tumor volume measurements: comparison of different primary sites. Clin Exp Otorhinolaryngol 2:78–84PubMedCrossRef

Dische S, Anderson PJ, Sealy R, Watson ER (1983) Carcinoma of the cervix—anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol 56:251–255PubMedCrossRef

Dubben HH, Thames HD, Beck-Bornholdt HP (1998) Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol 47:167–174PubMedCrossRef

10.

Goudakos JK, Markou K, Nikolaou A et al (2009) Management of the clinically negative neck (N0) of supraglottic laryngeal carcinoma: a systematic review. Eur J Surg Oncol 35:223–229PubMedCrossRef

11.

Gilbert RW, Birt D, Shulman H et al (1987) Correlation of tumor volume with local control in laryngeal carcinoma treated by radiotherapy. Ann Otol Rhinol Laryngol 96:514–518PubMed

12.

Grosu AL, Piert M, Weber WA et al (2005) Positron emission tomography for radiation treatment planning. Strahlenther Onkol 181:483–499PubMedCrossRef

13.

Hamilton S, Venkatesan V, Matthews TW et al (2004) Computed tomographic volumetric analysis as a predictor of local control in laryngeal cancers treated with conventional radiotherapy. J Otolaryngol 33:289–294PubMedCrossRef

14.

Hoebers FJ, Pameijer FA, Bois J de et al (2008) Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma. Head Neck 30:1216–1223PubMedCrossRef

15.

Horsman MR, Overgaard J (2002) Overcoming tumor radioresistance reulting from hypoxia. In: Steel GG (eds) Basic Clinical Radiobiology, 3rd edn. Arnold Publishers, pp 169–181

16.

Johnson CR, Thames HD, Huang DT, Schmidt-Ullrich RK (1995) The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int J Radiat Oncol Biol Phys 33:281–287PubMedCrossRef

17.

Kimura Y, Sumi M, Ichikawa Y et al (2005) Volumetric MR imaging of oral, maxillary sinus, oropharyngeal, and hypopharyngeal cancers: correlation between tumor volume and lymph node metastasis. Am J Neuroradiol 26:2384–2389PubMed

18.

Knegjens JL, Hauptmann M, Pameijer FA et al (2011) Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer. Head Neck 33:375–382PubMed

19.

Kraas JR, Underhill TE, D’Agostino RB Jr et al (2001) Quantitative analysis from CT is prognostic for local control of supraglottic carcinoma. Head Neck 23:1031–1036PubMedCrossRef

20.

Kurek R, Kalogera-Fountzila A, Muskalla K et al (2003) Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Strahlenther Onkol 179(5):292–297PubMedCrossRef

21.

Lo SM, Venkatesan V, Matthews TW, Rogers J (1998) Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma. J Otolaryngol 27:247–251PubMed

22.

Lund C, Jørgensen K, Hjelm-Hansen M, Andersen AP (1979) Laryngeal carcinoma. III. Treatment results in relation to microscopic score. Acta Radiol Oncol Radiat Phys Biol 18:497–508PubMedCrossRef

23.

Mancuso AA, Mukherji SK, Schmalfuss I et al (1999) Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol 17:631–637PubMed

24.

McRackan TR, Watkins JM, Herrin AE et al (2008) Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope 118:1180–1185PubMedCrossRef

25.

Mendenhall WM, Parsons JT, Mancuso AA et al (1996) Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck 18:24–35PubMedCrossRef

26.

Mukherji SK, Mancuso AA, Mendenhall W et al (1995) Can pretreatment CT predict local control of T2 glottic carcinomas treated with radiation therapy alone? AJNR Am J Neuroradiol 16:655–662PubMed

27.

Ottosson S, Zackrisson B, Kjellén E et al (2012) Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy. Acta Oncol 29:1–8

28.

Overgaard J, Hansen HS, Jørgensen K, Hjelm Hansen M (1986) Primary radiotherapy of larynx and pharynx carcinoma—an analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys 12:515–521PubMedCrossRef

29.

Pameijer FA, Mancuso AA, Mendenhall WM et al (1997) Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys 37:1011–1021PubMedCrossRef

30.

Pameijer FA, Balm AJ, Hilgers FJ, Muller SH (1997) Variability of tumor volumes in T3-staged head and neck tumors. Head Neck 19:6–13PubMedCrossRef

31.

Park GC, Kim JS, Roh JL, Choi SH et al (2013) Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx. Ann Oncol 24:208–214PubMedCrossRef

32.

Reddy SP, Hong RL, Nagda S, Emami B (2007) Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. Int J Radiat Oncol Biol Phys 69:1389–1394PubMedCrossRef

33.

Rutkowski T, Wygoda A, Składowski K et al (2012) Predictors of radiotherapy outcome in patients with T2 supraglottic carcinoma. Eur Arch Otorhinolaryngol 269:923–929PubMedCrossRef

34.

Sadat F, Wienke A, Dunst J, Kuhnt T (2012) Survival of patients with head and neck cancer. Impact of physical status and comorbidities. Strahlenther Onkol 188:62–70PubMedCrossRef

35.

Sessions DG, Lenox J, Spector GJ (2005) Supraglottic laryngeal cancer: analysis of treatment results. Laryngoscope 115:1402–1410PubMedCrossRef

36.

Strongin A, Yovino S, Taylor R et al (2012) Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys 82:1823–1830PubMedCrossRef

37.

Studer G, Lütolf UM, El-Bassiouni M et al (2007) Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT. Acta Oncol 46:386–394PubMedCrossRef

38.

Wygoda A, Składowski K, Rutkowski T et al (2012) Acute mucosal radiation reactions in patients with head and neck cancer. Patterns of mucosal healing on the basis of daily examinations. Strahlenther Onkol 188:686–691PubMedCrossRef

Titel: Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer
verfasst von: T. Rutkowski
A. Wygoda
K. Składowski
B. Hejduk
R. Rutkowski
Z. Kołosza
B. Maciejewski
Publikationsdatum: 01.10.2013
Verlag: Springer Berlin Heidelberg
Erschienen in: Strahlentherapie und Onkologie / Ausgabe 10/2013
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-013-0411-5

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer

Abstract

Background and purpose

Material and methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Update Onkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background and purpose

Material and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2013

Locally advanced verrucous carcinoma of the oral cavity

DEGRO practical guidelines: radiotherapy of breast cancer I

PRIMO: A graphical environment for the Monte Carlo simulation of Varian and Elekta linacs

Definitive radiation therapy for treatment of laryngeal carcinoma

Zweitmalignome nach Strahlentherapie beim Mammakarzinom

Zum Gedenken an Prof. Dr. Kian Ang

Neu im Fachgebiet Onkologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Update Onkologie